These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 29273271)

  • 1. Clozapine use in patients with schizophrenia and a comorbid substance use disorder: A systematic review.
    Arranz B; Garriga M; García-Rizo C; San L
    Eur Neuropsychopharmacol; 2018 Feb; 28(2):227-242. PubMed ID: 29273271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substance abuse in schizophrenia: a review.
    Buckley PF
    J Clin Psychiatry; 1998; 59 Suppl 3():26-30. PubMed ID: 9541335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy, acceptability and tolerability of antipsychotics in patients with schizophrenia and comorbid substance use. A systematic review and meta-analysis.
    Krause M; Huhn M; Schneider-Thoma J; Bighelli I; Gutsmiedl K; Leucht S
    Eur Neuropsychopharmacol; 2019 Jan; 29(1):32-45. PubMed ID: 30472164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacotherapy of schizophrenia with comorbid substance use disorder--reviewing the evidence and clinical recommendations.
    Wobrock T; Soyka M
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1375-85. PubMed ID: 18394768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipsychotic drug treatment of schizophrenic patients with substance abuse disorders.
    San L; Arranz B; Martinez-Raga J
    Eur Addict Res; 2007; 13(4):230-43. PubMed ID: 17851245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical practice guideline on pharmacological and psychological management of adult patients with schizophrenia spectrum disorders and a comorbid substance use.
    Arranz B; Garriga M; Bernardo M; González-Pinto A; Arrojo M; Torrens M; Tirado-Muñoz J; Fonseca F; Sáiz PA; Flórez G; Goikolea JM; Zorrilla I; Cunill R; Castells X; Becoña E; López A; San L
    Adicciones; 2022 Apr; 34(2):110-127. PubMed ID: 33768260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alcohol and cannabis use in schizophrenia: effects of clozapine vs. risperidone.
    Green AI; Burgess ES; Dawson R; Zimmet SV; Strous RD
    Schizophr Res; 2003 Mar; 60(1):81-5. PubMed ID: 12505141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological treatment of schizophrenia with comorbid substance use disorder.
    Azorin JM; Simon N; Adida M; Belzeaux R
    Expert Opin Pharmacother; 2016; 17(2):231-53. PubMed ID: 26635059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term Administration of Antipsychotic Drugs in Schizophrenia and Influence of Substance and Drug Abuse on the Disease Outcome.
    Werner FM; Covenas R
    Curr Drug Abuse Rev; 2017; 10(1):19-24. PubMed ID: 29065847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
    Krzystanek M; Krupka-Matuszczyk I
    Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schizophrenia and comorbid substance use disorder: effects of antipsychotics.
    Green AI
    J Clin Psychiatry; 2005; 66 Suppl 6():21-6. PubMed ID: 16107180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacotherapy of schizophrenia and comorbid substance use disorder. A systematic review].
    Wobrock T; D'Amelio R; Falkai P
    Nervenarzt; 2008 Jan; 79(1):17-8, 20-2, 24-6 passim. PubMed ID: 17619840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clozapine for substance-abusing schizophrenic patients.
    Tsuang JW; Eckman TE; Shaner A; Marder SR
    Am J Psychiatry; 1999 Jul; 156(7):1119-20. PubMed ID: 10401473
    [No Abstract]   [Full Text] [Related]  

  • 14. Novel antipsychotic medications and the treatment of comorbid substance abuse in schizophrenia.
    Buckley PF
    J Subst Abuse Treat; 1998; 15(2):113-6. PubMed ID: 9561949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of clozapine treatment on the improvement of substance use disorders other than nicotine in individuals with schizophrenia spectrum disorders: A systematic review and meta-analysis.
    Rafizadeh R; Danilewitz M; Bousman CA; Mathew N; White RF; Bahji A; Honer WG; Schütz CG
    J Psychopharmacol; 2023 Feb; 37(2):135-143. PubMed ID: 36507548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of clozapine on aggression and substance abuse in schizophrenic patients.
    Volavka J
    J Clin Psychiatry; 1999; 60 Suppl 12():43-6. PubMed ID: 10372611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of schizophrenia and comorbid substance abuse: pharmacologic approaches.
    Green AI
    J Clin Psychiatry; 2006; 67 Suppl 7():31-5; quiz 36-7. PubMed ID: 16961422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing the effect of clozapine and risperidone on cue reactivity in male patients with schizophrenia and a cannabis use disorder: A randomized fMRI study.
    Machielsen MWJ; Veltman DJ; van den Brink W; de Haan L
    Schizophr Res; 2018 Apr; 194():32-38. PubMed ID: 28351544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of clozapine on substance use in patients with schizophrenia and schizoaffective disorder: a retrospective survey.
    Zimmet SV; Strous RD; Burgess ES; Kohnstamm S; Green AI
    J Clin Psychopharmacol; 2000 Feb; 20(1):94-8. PubMed ID: 10653215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ziprasidone versus clozapine in the treatment of dually diagnosed (DD) patients with schizophrenia and cannabis use disorders: a randomized study.
    Schnell T; Koethe D; Krasnianski A; Gairing S; Schnell K; Daumann J; Gouzoulis-Mayfrank E
    Am J Addict; 2014; 23(3):308-12. PubMed ID: 24628830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.